Zobrazeno 1 - 7
of 7
pro vyhledávání: '"nebivololum"'
Publikováno v:
КардиоСоматика, Vol 9, Iss 1, Pp 10-16 (2018)
Increase in mortality from cardiovascular causes, systemic thromboembolism, congestive heart failure, increased frequency of hospitalization and deterioration in quality of life is associated with atrial fibrillation (AF). Essential hypertension (EH)
Externí odkaz:
https://doaj.org/article/bcc47ca73e264c39bcf9f3ac7e3766dd
Publikováno v:
Системные гипертензии, Vol 14, Iss 4, Pp 20-26 (2017)
Objective. Compare the effectiveness of treatment with nebivololum or sotalolum in patients with paroxysmal supraventricular tachycardia (SVT) on a background of essential hypertension (EH) taking into account quantitative evaluation of the regulator
Externí odkaz:
https://doaj.org/article/0af0c329b82b4880952f0d92ed836fa6
Publikováno v:
Системные гипертензии, Vol 14, Iss 4, Pp 20-26 (2017)
Objective. Compare the effectiveness of treatment with nebivololum or sotalolum in patients with paroxysmal supraventricular tachycardia (SVT) on a background of essential hypertension (EH) taking into account quantitative evaluation of the regulator
Externí odkaz:
https://doaj.org/article/a30b5d14e6af430da2d0f498f9e93d47
Publikováno v:
Системные гипертензии, Vol 13, Iss 4, Pp 30-35 (2016)
Aim: compare the effectiveness of treatment with nebivololum or sotalolum in patients with hypertensive disease (HD) and paroxysmal atral fibrillation (AF) taking into account quantitative evaluation of the regulatory adaptive status (RAS). Materials
Externí odkaz:
https://doaj.org/article/1d973402915c454aa06e5cab58a67c4d
Publikováno v:
КардиоСоматика, Vol 9, Iss 1, Pp 10-16 (2018)
Increase in mortality from cardiovascular causes, systemic thromboembolism, congestive heart failure, increased frequency of hospitalization and deterioration in quality of life is associated with atrial fibrillation (AF). Essential hypertension (EH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a24af73d48f4cb268335577bb7395ee
https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45931/pdf
https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45931/pdf
Publikováno v:
Системные гипертензии, Vol 14, Iss 4, Pp 20-26 (2017)
Objective. Compare the effectiveness of treatment with nebivololum or sotalolum in patients with paroxysmal supraventricular tachycardia (SVT) on a background of essential hypertension (EH) taking into account quantitative evaluation of the regulator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366bb9f8274118e96168c610f87e0948
https://syst-hypertension.ru/2075-082X/article/viewFile/29202/pdf
https://syst-hypertension.ru/2075-082X/article/viewFile/29202/pdf
Publikováno v:
Системные гипертензии, Vol 13, Iss 4, Pp 30-35 (2016)
Aim: compare the effectiveness of treatment with nebivololum or sotalolum in patients with hypertensive disease (HD) and paroxysmal atral fibrillation (AF) taking into account quantitative evaluation of the regulatory adaptive status (RAS). Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2803186c2ccd413b765357394d2ed0
https://syst-hypertension.ru/2075-082X/article/viewFile/29151/pdf
https://syst-hypertension.ru/2075-082X/article/viewFile/29151/pdf